In an open-label pilot of eight older adults, 24 weeks of GlyNAC (glycine plus N-acetylcysteine) corrected glutathione deficiency and improved markers of oxidative stress, inflammation, strength, gait speed and cognition, with benefits declining after 12 weeks off the supplement. With eight people, no placebo group and no numbers in the abstract, this is a hypothesis for larger trials rather than evidence of benefit.
A review of 17 studies (ten cross-sectional, seven longitudinal) of healthy adults found discrete differences in diversity indexes and in the abundance of certain bacteria in active people. The abstract names no specific bacteria or effect sizes, and the studies varied in design, so the link remains loosely defined.
In a crossover trial of 26 people with Alzheimer's disease, a 12-week modified ketogenic diet raised daily-function scores (ADCS-ADL +3.13 points, P = 0.0067) and quality-of-life scores (QOL-AD +3.37, P = 0.023) versus usual diet, but not cognition (ACE-III +2.12, P = 0.24). The trial was very small, and the abstract does not report any long-term follow-up.
In health care workers wearing an Apple Watch, the circadian amplitude of an HRV measure (SDNN) differed between people with and without COVID-19 (P=.006) and in the 7 days around diagnosis versus uninfected periods (P=.01). The abstract gives no participant numbers or accuracy, so its value as an individual warning is unproven.
Of 22 observational studies reviewed, 21 found that higher self-efficacy went with more self-care in adults with hypertension, including medication adherence (9 studies), physical activity (2) and diet (1). The evidence was rated low to medium quality, limited by heterogeneity and self-reported behaviour.
In an online survey of 387 current or past CBD users, the top reasons for use were self-perceived anxiety (42.6%), sleep problems (42.5%) and stress (37%), and respondents said CBD worked for those problems. The sample was self-selected and mostly UK-based, and the effects are self-perceived, not measured.
In 74 people with fatty liver (NAFLD), 12 weeks of a 5:2 diet or a low-carb high-fat diet reduced liver fat by 6.1% and 7.2% in absolute terms, versus 3.6% with general lifestyle advice. The trial was open-label and small, so it cannot tell us whether the benefit lasts beyond 12 weeks.
In two population-based German samples of 855 children aged 4-9 and 1,047 adolescents aged 10-17, 22.6% of children and 20.0% of adolescents had a problematic amount of sleep difficulties. The data are parent- or self-reported questionnaires from one cohort, so they describe patterns and cannot show why they arise.
In a Brazilian clinical trial, healthy community-dwelling older adults who did 24 group sessions of dual-task exercise improved on episodic memory, sustained visual attention, mobility, fitness, leg strength, agility and quality of life, while a non-exercise control group did not. The abstract gives no sample size or effect sizes, so the size of benefit cannot be judged.
Pooling 12 papers, a low-FODMAP diet lowered irritable bowel syndrome severity more than control diets (standardized mean difference -0.66, 95% CI -0.88 to -0.44) and raised quality-of-life scores. The trials were few and varied in design, and the abstract leaves long-term nutrition and gut-microbiome effects unanswered.
Among 5395 UK adults using the BetterPoints app, median weekly activity by the first full week of lockdown was 57 minutes below baseline, a 37% reduction, and 63% of people were less active. These users were self-selected app users with a mean age of 41, so they do not represent the whole UK population.
In wearable data from 1,824 city-dwelling working adults aged 21-40, time in bed rose by 20 min and resting heart rate fell by ~2 bpm during lockdown, while physical activity dropped an average of 42%. The least active group (~51% of the sample) lost the most activity, but the data cover only young working adults in the early lockdown.
In 37 041 UK Biobank participants with brain MRI, white matter hyperintensities (WMH) were most strongly associated with past diastolic blood pressure (β = 0.087), particularly under age 50 (β = 0.103), though concurrent systolic pressure also mattered. These are associations in an observational cohort, so they do not show that lowering blood pressure shrinks WMH.
In an Australian online survey during April-May 2020 stay-at-home rules, adults using digital platforms for exercise were likelier to meet strength guidelines (OR 3.3, 95% CI 2.5-4.5) and moderate-to-vigorous guidelines (OR 2.0, 95% CI 1.5-2.7). Adolescents showed a similar pattern, but this self-reported cross-sectional survey cannot show the platforms caused it.
In a pilot randomised trial of 99 cognitively normal adults aged 60-80, 6 months of cycling raised fitness more in the high-intensity group than in the moderate-intensity and control groups, but there was no direct effect of exercise on cognition. As a pilot, it was not powered to detect small cognitive effects or explain individual differences.
In 320 Hong Kong adults aged 60 or older with chronic insomnia, 12 weeks of tai chi or conventional exercise raised wrist-actigraphy sleep efficiency by about 3.5 percentage points versus no intervention (tai chi +3.4%, 95% CI 1.6-5.1), and gains lasted to 24 months. The improvements were modest in absolute terms and came from a single research site.
Mendelian randomization using genetic predisposition to type 2 diabetes and higher HbA1c found associations with higher risk of any ischemic stroke, large artery stroke and small vessel stroke, plus markers of brain small-vessel disease and atrophy. The abstract gives no effect sizes, and the method relies on assumptions about genetic variants that cannot be fully verified.
A systematic review of 44 studies on commercially available resistance-training monitors found that most did not use a gold-standard criterion measure, so device errors may be under- or over-reported. Linear transducers appeared more accurate and reliable than other device types, but the abstract gives no per-device numbers.